: Exploris 480 Orbitrap Mass Spectrometry and Ultra-High Performance Liquid Chromatography (UHPLC) System
ID: NOI-FDA-SS-116392 • Type: Special Notice
Overview
Response Deadline
Feb. 3, 2023, 8:00 a.m. EST
Past Due
Posted
Jan. 23, 2023, 9:59 a.m. EST
Set Aside
None
Place of Performance
Saint Louis, MO 63110
USA
Source
Current SBA Size Standard
1000 Employees
Pricing
Likely Fixed Price
Est. Level of Competition
Sole Source
On 1/23/23 Food and Drug Administration issued Special Notice NOI-FDA-SS-116392 for : Exploris 480 Orbitrap Mass Spectrometry and Ultra-High Performance Liquid Chromatography (UHPLC) System due 2/3/23.
Primary Contact
Documents
Posted documents for Special Notice NOI-FDA-SS-116392
Question & Answer
Incumbent or Similar Awards
Potential Bidders and Partners
Awardees that have won contracts similar to Special Notice NOI-FDA-SS-116392
Similar Active Opportunities
Open contract opportunities similar to Special Notice NOI-FDA-SS-116392
Additional Details
Source Agency Hierarchy
HEALTH AND HUMAN SERVICES, DEPARTMENT OF > FOOD AND DRUG ADMINISTRATION > FDA OFFICE OF ACQ GRANT SVCS
FPDS Organization Code
7524-00223
Source Organization Code
100188033
Last Updated
Jan. 23, 2023
Last Updated By
nicole.craig@fda.hhs.gov
Archive Date
Jan. 23, 2023